Head of Product Development, NTD Leishmaniasis-Mycetoma Cluster, DNDi
Alistair Swanson joined DNDi as Head of Product Development for HIV & Hepatitis C Initiative in January 2018. Since February 2022, Alistair is Head of Product Development for leishmaniasis and mycetoma (NTD Leishmaniasis-Mycetoma Cluster).
Alistair has a degree and doctorate in Chemistry and over 30 years’ experience in the Pharma industry, initially with Pfizer R&D then, for the last seven and a half years, as an independent consultant. In Pfizer, he held a variety of management and leadership positions, with a focus on new product development, registration, and portfolio management. He also led several large business integration and process change projects.
In addition to DNDi, he has worked as a consultant with a range of large and small R&D organisations in Pharma and other regulated industries to develop technical and regulatory strategies and implement effective project and portfolio management systems.
Get our latest news, personal stories, research articles, and job opportunities.